GAD65-Reactive T cells in a Non-diabetic Stiff-man Syndrome Patient

This publication has 32 references indexed in Scilit:

• T-Cell Responses to Autoantigens in IDDM: The Search for the Holy Grail
  Diabetes, 1996
• Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.
  The Journal of Experimental Medicine, 1996
• Identification of Glutamic Acid Decarboxylase Autoantibody Heterogeneity and Epitope Regions in Type I Diabetes
  Diabetes, 1994
• The Exon-Intron Organization of the Genes (GAD1 and GAD2) Encoding Two Human Glutamate Decarboxylases (GAD67 and GAD65) Suggests That They Derive from a Common Ancestral GAD
  Genomics, 1994
• GAD Autoantibodies in IDDM, Stiff-Man Syndrome, and Autoimmune Polyendocrine Syndrome Type I Recognize Different Epitopes
  Diabetes, 1994
• Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes
  Nature, 1993
• Recombinant Glutamic Acid Decarboxylase (Representing the Single Isoform Expressed in Human Islets) Detects IDDM-Associated 64,000-Mr Autoantibodies
  Diabetes, 1992
• Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes
  The Lancet, 1992
• Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
  Nature, 1990
• Stiff-Man Syndrome Updated
  Mayo Clinic Proceedings, 1989